BL
EW icon

BFSG LLC’s Edwards Lifesciences EW Stock Holding History

BFSG LLC’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$635K Sell
7,025
-365
-5% -$30.6K 0.06% 188
2026
Q1 		$592K Sell
7,390
-20
-0.3% -$1.65K 0.06% 184
2025
Q4 		$632K Buy
7,410
+1,200
+19% +$98.5K 0.06% 179
2025
Q3 		$483K Hold
6,210
– – 0.05% 200
2025
Q2 		$486K Hold
6,210
– – 0.05% 186
2025
Q1 		$450K Sell
6,210
-45
-0.7% -$3.22K 0.05% 182
2024
Q4 		$463K Hold
6,255
– – 0.05% 181
2024
Q3 		$413K Sell
6,255
-840
-12% -$61K 0.05% 187
2024
Q2 		$655K Hold
7,095
– – 0.08% 165
2024
Q1 		$678K Hold
7,095
– – 0.09% 163
2023
Q4 		$541K Sell
7,095
-300
-4% -$20.9K 0.08% 168
2023
Q3 		$512K Hold
7,395
– – 0.08% 165
2023
Q2 		$698K Hold
7,395
– – 0.12% 167
2023
Q1 		$612K Sell
7,395
-1,020
-12% -$80.2K 0.11% 159
2022
Q4 		$628K Sell
8,415
-562
-6% -$43.3K 0.13% 147
2022
Q3 		$742K Hold
8,977
– – 0.16% 124
2022
Q2 		$854K Buy
+8,977
New +$929K 0.15% 131
2022
Q1 		– Sell
-9,027
Closed -$1.17M – 210
2021
Q4 		$1.17M Sell
9,027
-500
-5% -$58.3K 0.16% 129
2021
Q3 		$1.08M Buy
+9,527
New +$1.09M 0.16% 128
2021
Q2 		– Sell
-9,672
Closed -$809K – 156
2021
Q1 		$809K Hold
9,672
– – 0.13% 146
2020
Q4 		$882K Hold
9,672
– – 0.15% 126
2020
Q3 		$772K Hold
9,672
– – 0.14% 119
2020
Q2 		$668K Hold
9,672
– – 0.14% 111
2020
Q1 		$608K Hold
9,672
– – 0.16% 106
2019
Q4 		$752K Buy
+9,672
New +$755K 0.14% 125
2018
Q3 		– Sell
-8,901
Closed -$432K – 127
2018
Q2 		$432K Buy
8,901
+1,602
+22% +$74.8K 0.19% 100
2018
Q1 		$339K Buy
+7,299
New +$317K 0.15% 111

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $1.85B AUM 62.46% 1-Year Est. Return

BFSG LLC's EW Position: Q2 2026 in Review

BFSG LLC reduced its Edwards Lifesciences (EW) stake by 4.9% in Q2 2026, selling an estimated $30.6K and leaving 7,025 shares worth $635K. The position accounts for 0.06% of the portfolio, ranked #188.

BFSG LLC first reported a position in EW in Q1 2018 and has held it in 27 quarters since. The position peaked at $1.17M in Q4 2021. 227 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • BFSG LLC held 7,025 shares of Edwards Lifesciences worth $635K as of Q2 2026.
  • BFSG LLC sold 365 Edwards Lifesciences shares in Q2 2026, an estimated $30.6K.
  • Edwards Lifesciences made up 0.06% of BFSG LLC's portfolio in Q2 2026, its #188 holding.
  • BFSG LLC first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 27 quarters since.
  • BFSG LLC's Edwards Lifesciences position peaked at $1.17M in Q4 2021.
  • 227 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.